Video/Audio

April 9-12, 2018

The Great Oncolytic Debate: For the success of oncolytic viruses – single cycle cures or repeat treatments?

Oxford, UK

Stephen J. Russell, M.D., Ph.D., Vyriad CEO, has been invited to Chair, Innate and collateral adaptive tumor immunity. Dr. Russell will also participate in Steve Russell (Once should be enough!) vs. Alan Melcher (Repeat dosing is crucial!)

June 26, 2016

This Week in Virology

TWIV

Video podcast with featured guest Stephen Russell, MD, PhD, CEO & President of Vyriad

February 27, 2015

Star Tribune

“VICE Special Report: Killing Cancer”

October 24, 2014

Mayo Clinic

Serendipity: How a Cancer-Fighting Measles Virus Brought Together Patient and Benefactors